CO2 soil flux baseline at the technological development plant for CO2 injection at Hontomin (Burgos, Spain)

From the end of 2013 and during the following two years, 20 kt of CO2sc are planned to be injected in a saline reservoir (1500 m depth) at the Hontomín site (NE Spain). The target aquifers are Lower Jurassic limestone formations which are sealed by Lower Cretaceous clay units at the Hontomín site (NE Spain). The injection of CO2 is part of the activities committed in the Technology Development phase of the EC-funded OXYCFB300 project (European Energy Program for Recovery – EEPR, http://www.compostillaproject.eu), which include CO2 injection strategies, risk assessment, and testing and validating monitoring methodologies and techniques. Among the monitoring works, the project is intended to prove that present-day technology is able to monitor the evolution of injected CO2 in the reservoir and to detect potential leakage. One of the techniques is the measurement of CO2 flux at the soil–atmosphere interface, which includes campaigns before, during and after the injection operations. In this work soil CO2 flux measurements in the vicinity of oil borehole, drilled in the eighties and named H-1 to H-4, and injection and monitoring wells were performed using an accumulation chamber equipped with an IR sensor. Seven surveys were carried out from November 2009 to summer 2011. More than 4000 measurements were used to determine the baseline flux of CO2 and its seasonal variations. The measured values were low (from 5 to 13 g m−2 day−1) and few outliers were identified, mainly located close to the H-2 oil well. Nevertheless, these values cannot be associated to a deep source of CO2, being more likely related to biological processes, i.e. soil respiration. No anomalies were recognized close to the deep fault system (Ubierna Fault) detected by geophysical investigations. There, the CO2 flux is indeed as low as other measurement stations. CO2 fluxes appear to be controlled by the biological activity since the lowest values were recorded during autumn-winter seasons and they tend to increase in warm periods. Two reference CO2 flux values (UCL50 of 5 g m−2 d−1 for non-ploughed areas in autumn–winter seasons and 3.5 and 12 g m−2 d−1 for in ploughed and non-ploughed areas, respectively, in spring–summer time, and UCL99 of 26 g m−2 d−1 for autumn–winter in not-ploughed areas and 34 and 42 g m−2 d−1 for spring–summer in ploughed and not-ploughed areas, respectively) were calculated. Fluxes higher than these reference values could be indicative of possible leakage during the operational and post-closure stages of the storage project

Hubs and clusters approach to unlock the development of carbon capture and storage - Case study in Spain

Many countries have assigned an indispensable role for carbon capture and storage (CCS) in their national climate change mitigation pathways. However, CCS deployment has stalled in most countries with only limited commercial projects realised mainly in hydrocarbon-rich countries for enhanced oil recovery. If the Paris Agreement is to be met, then this progress must be replicated widely, including hydrocarbon-limited countries. In this study, we present a novel source-to-sink assessment methodology based on a hubs and clusters approach to identify favourable regions for CCS deployment and attract renewed public and political interest in viable deployment pathways. Here, we apply this methodology to Spain, where fifteen emission hubs from both the power and the hard-to-abate industrial sectors are identified as potential CO2 sources. A priority storage structure and two reserves for each hub are selected based on screening and ranking processes using a multi-criteria decision-making method. The priority source-to-sink clusters are identified indicating four potential development regions, with the North-Western and North-Eastern Spain recognised as priority regions due to resilience provided by different types of CO2 sources and geological structures. Up to 68.7 Mt CO2 per year, comprising around 21% of Spanish emissions can be connected to clusters linked to feasible storage. CCS, especially in the hard-to-abate sector, and in combination with other low-carbon energies (e.g., blue hydrogen and bioenergy), remains a significant and unavoidable contributor to the Paris Agreement's mid-century net-zero target. This study shows that the hubs and clusters approach can facilitate CCS deployment in Spain and other hydrocarbon-limited countries

Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II)

Background: Mesenchymal stromal cells (MSCs) are a promising option to treat knee osteoarthritis (OA). Their safety and usefulness have been reported in several short-term clinical trials but less information is available on the longterm efects of MSC in patients with osteoarthritis. We have evaluated patients included in our previous randomized clinical trial (CMM-ART, NCT02123368) to determine their long-term clinical efect. Materials: A phase I/II multicenter randomized clinical trial with active control was conducted between 2012 and 2014. Thirty patients diagnosed with knee OA were randomly assigned to Control group, intraarticularly administered hyaluronic acid alone, or to two treatment groups, hyaluronic acid together with 10×106 or 100×106 cultured autol‑ ogous bone marrow-derived MSCs (BM-MSCs), and followed up for 12 months. After a follow up of 4 years adverse efects and clinical evolution, assessed using VAS and WOMAC scorings are reported. Results: No adverse efects were reported after BM-MSCs administration or during the follow-up. BM-MSCs-adminis‑ tered patients improved according to VAS, median value (IQR) for Control, Low-dose and High-dose groups changed from 5 (3, 7), 7 (5, 8) and 6 (4, 8) to 7 (6, 7), 2 (2, 5) and 3 (3, 4), respectively at the end of follow up (Low-dose vs Control group, p=0.01; High-dose vs Control group, p=0.004). Patients receiving BM-MSCs also improved clinically accord‑ ing to WOMAC. Control group showed an increase median value of 4 points (−11;10) while Low-dose and Highdose groups exhibited values of −18 (−28;−9) and −10 (−21;−3) points, respectively (Low-dose vs Control group p=0.043). No clinical diferences between the BM-MSCs receiving groups were found. Conclusions: Single intraarticular injection of in vitro expanded autologous BM-MSCs is a safe and feasible proce‑ dure that results in long-term clinical and functional improvement of knee OA

Prevalence of malnutrition and its etiological factors in hospitals Prevalencia de malnutrición y sus factores etiológicos en hospitales

Background: Malnutrition among inpatients is highly prevalent, and has a negative impact on their clinical outcome. The Working Group for the Study of Malnutrition in Hospitals in Catalonia was created to generate consensus guidelines for the prevention and/or treatment of malnutrition in hospitals in Catalonia, Spain. Aims: The objectives of the study were to determine the prevalence of malnutrition on admission to hospital in Catalonia and to assess relationships between malnutrition, social and demographic data, overall costs, and mortality. Methods: Prospective and multicenter study conducted with 796 patients from 11 hospitals representative of the hospitalized population in Catalonia. Nutritional status was evaluated using the Nutritional Risk Screening 2002 method. Results: Overall, 28.9% of the patients are malnourished or at nutritional risk. Elderly patients, non-manual workers, those admitted to hospital as emergencies and with higher co-morbidities had higher risk of malnutrition. The type of hospital (second level vs. tertiary or University referral) to which they were admitted was also a factor predisposing to malnutrition. Length of hospital stay was longer in malnourished patients (10.5 vs. 7.7 days, p Introducción: La desnutrición en los pacientes ingresados en el hospital es altamente prevalente, e impacta negativamente en su evolución clínica. El Grupo de Trabajo para el Estudio de la Desnutrición Hospitalaria en Cataluña se creó para general Guías de consenso para prevenir y/o tratar la desnutrición en los hospitales de Cataluña, España. Objetivos: Los objetivos del estudio fueron determinar la prevalencia de desnutrición al ingreso en los hospitales de Cataluña, y evaluar la relación entre desnutrición, datos sociales y demográficos, coste relacionado con la enfermedad y mortalidad. Métodos: Estudio prospectivo y multicéntrico realizado en 796 pacientes ingresados en 11 hospitales representativos de la población hospitalizada en Cataluña. El estado nutricional se evaluó utilizando la herramienta Nutritional Risk Screening 2002. Resultados: De forma global, 28,9% de los pacientes estaban desnutridos en el momento del ingreso. Los pacientes más ancianos, trabajadores no manuales, ingresados en el hospital procedentes de Urgencias y con más comorbilidades son los que presentaron mayor prevalencia de desnutrición. El tipo de hospital (Segundo nivel versus Tercer Nivel) también fue un factor predisponerte a la desnutrición. La estancia hospitalaria fue mayor en los pacientes desnutridos (10,5 vs 7,7 días, p < 0,0001). La necesidad de centro de convalecencia al alta hospitalaria fue mayor en los pacientes desnutridos, así como la mortalidad (8,6% desnutridos vs 1,3% normonutridos, p < 0,0001). Conclusiones: La prevalencia de desnutrición es elevada en los pacientes ingresados en el hospital en nuestra comunidad, lo que resulta en mayores costes sanitarios y mayor mortalidad. La edad, clase social y características del Servicio y del Hospital son los principales factores involucrados en la presencia de desnutrición hospitalaria